ABIOMED INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2012 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Abiomed Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2012 to Q1 2022.
  • Abiomed Inc Deferred Tax Assets, Valuation Allowance for the quarter ending March 31, 2022 was $19.4M, a 23.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $19.4M +$3.74M +23.9% Mar 31, 2022 10-K 2022-05-20
Q1 2021 $15.7M +$497K +3.28% Mar 31, 2021 10-K 2022-05-20
Q1 2020 $15.2M +$13.9M +1065% Mar 31, 2020 10-K 2021-05-21
Q1 2019 $1.3M -$350K -21.2% Mar 31, 2019 10-K 2020-05-21
Q1 2018 $1.65M -$816K -33.1% Mar 31, 2018 10-K 2019-05-23
Q1 2017 $2.47M +$50K +2.07% Mar 31, 2017 10-K 2018-05-24
Q1 2016 $2.42M -$494K -17% Mar 31, 2016 10-K 2017-05-25
Q1 2015 $2.91M -$99.2M -97.1% Mar 31, 2015 10-K 2016-05-26
Q1 2014 $102M -$4.58M -4.29% Mar 31, 2014 10-K 2015-05-28
Q1 2013 $107M -$11.6M -9.82% Mar 31, 2013 10-K 2014-05-28
Q1 2012 $118M Mar 31, 2012 10-K 2013-05-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.